Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party. The ...

A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...

Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

For Zevra Therapeutics, last year’s approval of the rare lysosomal storage disorder drug Miplyffa appears to be the gift that ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

A big change may be coming to vape shops in Tennessee. A proposed bill in the state House of Representatives and Senate would ban all non-Food and Drug ...

More than 20 civil service employees resigned Tuesday from Elon Musk's Department of Government Efficiency, saying they refused to use their technical expertise to "dismantle critical public services.

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.